← Leaderboards
Vijaya Pratha
University Of California San Diego
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Jerrold M Olefsky$29,583,289
- Dan M Cooper$93,323,130
- Thomas J. Kipps$21,947,102
- Robert Roy Henry$4,115,619
- John C Gillin$665,812
Others in their field
Top investigators on “Antifungal Antibiotics”
- Karen E. Nelson · J. Craig Venter Institute, Inc.$14,857,040
- William Charles Nierman · Institute For Genomic Research$14,857,040
- Cameron Robert Currie · University Of Wisconsin-Madison$11,322,269
- Jose L. Lopez-Ribot · University Of Texas San Antonio$7,368,218
- Gerald R Fink · Whitehead Institute For Biomedical Res$6,159,066
- David S Weiss · Univ Of North Carolina Chapel Hill$5,468,002
Research focus
Antifungal AntibioticsCandida AlbicansCandidiasisClinical ResearchFluconazoleHuman SubjectHuman Therapy EvaluationMicroorganism Disease Chemotherapy
Grant awards (9)
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2002 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2002 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2002 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2002 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2001 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2001 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2000 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2000 · RR
MK-0991 VS FLUCONAZOLE FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2000 · RR